Picture of Sana Biotechnology logo

SANA — Sana Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Uppsala University Hospital And Sana Biotechnology Announce Authorization

Nov 17 (Reuters) - Sana Biotechnology Inc  SANA.O :
    * UPPSALA UNIVERSITY HOSPITAL AND SANA BIOTECHNOLOGY
ANNOUNCE
AUTHORIZATION OF THE FIRST-IN-HUMAN CLINICAL TRIAL APPLICATION
FOR A PRIMARY ISLET CELL TREATMENT FOR PATIENTS WITH TYPE 1
DIABETES
    * SANA BIOTECHNOLOGY INC - GOAL IS TO REPORT UP421 PROOF OF
CONCEPT DATA IN 2023 AND 2024

Source text for Eikon:  ID:nGNXbBHh8K 
Further company coverage:  SANA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sana Biotechnology

See all news